In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II study
(Q34194680)
scientific article
scientific article
Language:
Current Data About
In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II study
other details
| description | scientific article |
External Links
| (P356) |
10.1200/JCO.2010.28.9793
|
| (P698) |
20697067
|
| (P932) |
2954133
|
| (P8608) |
release_5ji4npt6oba5vjfujownqa4njy
|